Huda Salman was named the first executive director of the Indiana University School of Medicine’s Brown Center for Immunotherapy, effective Nov. 1.
After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—including cancer, cystic fibrosis, and sickle cell disease.
